Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

What Makes a “Best Doctor” Best?

Christina Picciano  |  Issue: February 2011  |  February 12, 2011

While opting out of the peer-nomination process and focusing on increased data-driven analysis establishes an objectivity, it also presents difficulty in ranking other specialties, like rheumatology, where outcomes are not as measureable. Hoping to publish cross-specialty ratings, Dr. Santa urges rheumatologists to “look at what the STS has done and, within the discipline, start identifying the key performance measures that identify a good rheumatologist, and start collecting and sharing that information with other rheumatologists and physicians to hopefully arrive at something more objective in terms of performance [than reputation].”

Rheumatologists React

Until a more exact equation for defining physician quality is determined, however, these lists will likely have little bearing on physicians. Bruce Solitar, MD, clinical associate professor at NYU’s Hospital for Joint Diseases and a Manhattan-based rheumatologist, says that, although certain rankings are helpful in drawing new patients to his office and are, to a degree, self-assuring, he concedes, “I don’t think it makes me a better doctor because I’m on a list; I know there are many good doctors that aren’t. But, my mom loves to see my name on the list.” David Borenstein, MD, clinical professor of medicine in the division of rheumatology at The George Washington University Medical Center, Washington-based rheumatologist, and president of the ACR, tends to take Dr. Solitar’s ambivalent approach: “It’s a good thing to know that you’re doing a good job, but you get up every day, you go to work, try to do the best you can, and if it’s worthy of some recognition—great. But that clearly is the icing on the cake.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Christina Picciano is a writer based in New Jersey.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:dataphysicianPrimary Care Physiciansrankingrheumatologist

Related Articles

    Consumers Add Perspective to Arthritis Research

    November 1, 2006

    It has been my distinct pleasure to work with consumer collaborators—people living with arthritis—on research projects, advisory boards, and review panels, in consensus meetings to establish research agendas, and as co-educators in health professional programs. Those I work with have chosen the term “consumer collaborator” to reflect their contribution to and eventual use of our partnerships, although others might call them patients or clients.

    U.S. Doctor Group Calls for Ban on Drug Advertising to Consumers

    November 19, 2015

    (Reuters)—The American Medical Association on Tuesday called for a ban on advertising prescription drugs and medical devices directly to consumers, saying the ads drive patients to demand expensive treatments over less costly ones that are also effective. The influential doctors’ group said the new policy reflects physicians’ concerns that marketing spending on a proliferation of…

    Patients Get Mixed Reactions from Docs over Mail-Ordered Genetic Tests

    March 3, 2016

    (Reuters Health)—Patients who order direct-to-consumer genetic tests report mixed experiences when they take the results to their doctors, a new study found. About a quarter of people who ordered direct-to-consumer genetic testing from such companies as 23andMe reported discussing the results with their primary care doctors. But nearly one in five were not at all…

    Choosing Wisely: Recommendations from Medical Specialties Beyond Rheumatology

    October 1, 2014

    Practice gems that may help rheumatologists avoid performing costly patient tests, procedures of limited use

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences